PHARMACOKINETICS AND DOSAGE REQUIREMENTS OF NETILMICIN IN CYSTIC-FIBROSIS PATIENTS

[1] COMPUTATION OF MODEL-INDEPENDENT PHARMACOKINETIC PARAMETERS DURING MULTIPLE DOSING [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (08) : 978 - 979

[2] IS ANTI-PSEUDOMONAS THERAPY WARRANTED IN ACUTE RESPIRATORY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS [J]. JOURNAL OF PEDIATRICS, 1980, 97 (01) : 144 - 147

[3] BRASFIELD D, 1979, PEDIATRICS, V63, P24

[4] CRAIG WA, 1983, PHARMACOTHERAPY, V3, P305

[5] Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409

[6] NETILMICIN (NETROMYCIN, SCHERING-PLOUGH) [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (02): : 83 - 91

[7] JAHRE JA, 1978, CLIN PHARMACOL THER, V23, P591

[8] KEARNS GL, 1982, J PEDIATR-US, V100, P312, DOI 10.1016/S0022-3476(82)80663-X

[9] PHARMACOKINETICS OF TOBRAMYCIN IN CYSTIC-FIBROSIS [J]. JOURNAL OF PEDIATRICS, 1982, 100 (02) : 318 - 321

[10] DISPOSITION OF TOBRAMYCIN IN PATIENTS WITH CYSTIC-FIBROSIS - A PROSPECTIVE CONTROLLED-STUDY [J]. JOURNAL OF PEDIATRICS, 1984, 105 (01) : 117 - 124

[1] COMPUTATION OF MODEL-INDEPENDENT PHARMACOKINETIC PARAMETERS DURING MULTIPLE DOSING [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (08) : 978 - 979

[2] IS ANTI-PSEUDOMONAS THERAPY WARRANTED IN ACUTE RESPIRATORY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS [J]. JOURNAL OF PEDIATRICS, 1980, 97 (01) : 144 - 147

[3] BRASFIELD D, 1979, PEDIATRICS, V63, P24

[4] CRAIG WA, 1983, PHARMACOTHERAPY, V3, P305

[5] Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409

[6] NETILMICIN (NETROMYCIN, SCHERING-PLOUGH) [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (02): : 83 - 91

[7] JAHRE JA, 1978, CLIN PHARMACOL THER, V23, P591

[8] KEARNS GL, 1982, J PEDIATR-US, V100, P312, DOI 10.1016/S0022-3476(82)80663-X

[9] PHARMACOKINETICS OF TOBRAMYCIN IN CYSTIC-FIBROSIS [J]. JOURNAL OF PEDIATRICS, 1982, 100 (02) : 318 - 321

[10] DISPOSITION OF TOBRAMYCIN IN PATIENTS WITH CYSTIC-FIBROSIS - A PROSPECTIVE CONTROLLED-STUDY [J]. JOURNAL OF PEDIATRICS, 1984, 105 (01) : 117 - 124